Literature DB >> 6204972

Human urine DNase I: immunological identity with human pancreatic DNase I, and enzymic and proteochemical properties of the enzyme.

K Ito, N Minamiura, T Yamamoto.   

Abstract

DNase I in human urine was purified to an electrophoretically homogeneous state by column chromatographies on DEAE-lignocellulose, hydroxyapatite, DEAE-cellulose, Sephadex G-75 and elastin-celite. The purified enzyme was immunologically identical with human pancreatic DNase I, but not with bovine pancreatic DNase I. The molecular weight and isoelectric point of the enzyme were estimated to be 4.1 X 10(4) and 3.6, respectively. The amino acid analysis revealed that 1 mol of the enzyme contained 8 mol of half-cystine. The N-terminal amino acid was identified as leucine by the dansyl chloride method. The enzyme was active in the presence of Mg2+, Co2+, or Mn2+, The optimum pH was around 6.5. The enzyme was stable in the pH range from 5.0 to 9.0 and at temperatures lower than 45 degrees C. The rate of hydrolysis of native DNA by the enzyme was twice as fast as that observed with heat-denatured DNA. This enzyme exhaustively degraded about 20% of the phosphodiester bonds in native DNA. The enzyme also degraded poly(dA) and poly(dT), but hardly degraded poly(dG) and poly(dC).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204972     DOI: 10.1093/oxfordjournals.jbchem.a134747

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Genetic polymorphism of urine deoxyribonuclease I isomerases of subterranean mole rats, Spalax ehrenbergi superspecies, in Israel: ecogeographical patterns and correlates.

Authors:  E Nevo; K Kishi; A Beiles
Journal:  Biochem Genet       Date:  1990-12       Impact factor: 1.890

2.  Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis.

Authors:  Carolin Rauter; Markus Mueller; Isabel Diterich; Sabine Zeller; Dieter Hassler; Thomas Meergans; Thomas Hartung
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

3.  Human serum deoxyribonuclease I (DNase I) polymorphism: pattern similarities among isozymes from serum, urine, kidney, liver, and pancreas.

Authors:  K Kishi; T Yasuda; Y Ikehara; K Sawazaki; W Sato; R Iida
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

4.  Rabbit DNase I: purification from urine, immunological and proteochemical characterization, nucleotide sequence, expression in tissues, relationships with other mammalian DNases I and phylogenetic analysis.

Authors:  T Yasuda; H Takeshita; T Nakajima; O Hosomi; Y Nakashima; K Kishi
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

5.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 6.  Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals.

Authors:  Sandeep Yadav; Jun Liu; Thomas M Scherer; Yatin Gokarn; Barthélemy Demeule; Sonoko Kanai; James D Andya; Steven J Shire
Journal:  Biophys Rev       Date:  2013-03-14

7.  Genetic polymorphism of human urine deoxyribonuclease I.

Authors:  K Kishi; T Yasuda; S Awazu; K Mizuta
Journal:  Hum Genet       Date:  1989-02       Impact factor: 4.132

8.  Distinct Morphological Fates of Uropathogenic Escherichia coli Intracellular Bacterial Communities: Dependency on Urine Composition and pH.

Authors:  Gregory Iosifidis; Iain G Duggin
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

9.  Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential.

Authors:  O E Bryzgunova; P P Laktionov
Journal:  Acta Naturae       Date:  2015 Jul-Sep       Impact factor: 1.845

10.  Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Jaime Cok; Noelia Angulo; Hermes Escalante; Caryn Bern
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.